-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Indian Growth Stocks With At Least 24% Revenue Growth

Simply Wall St·11/02/2026 00:31:39
语音播报

Rising interest rates in the US are pressuring high growth tech stocks and pushing many investors to rethink how much risk they really want to take. That is where fast growing Indian companies with meaningful insider ownership become interesting. When founders keep substantial skin in the game, their incentives are closely tied to yours. This article walks through three such stocks from our screen and explains what makes each one worth a closer look.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders are heavily invested alongside you. However, if you want the absolute best, these 41 high growth high conviction stocks are the cream of the crop.

Rubicon Research (NSEI:RUBICON)

Rubicon Research plugs into this fast growing, insider aligned theme through its specialty drug formulations and proprietary delivery platforms that aim to turn complex molecules into higher value products. This gives growth focused investors a very different way to gain exposure to pharmaceuticals.

Rubicon Research develops specialty pharmaceutical products across pain, cardiovascular, central nervous system and other therapies. Its work is anchored by its RubiReten and RubiSRL drug delivery platforms. The company generates ₹19,358 million from pharmaceutical products while the stock is valued at about ₹266.6b in market cap.

"Expansion of US manufacturing capacity through the New Jersey facility and preparation of the Pithampur site in India is expected to support a higher own manufacturing share and can support gross margin resilience and operating EBITDA over time."

What happens to Rubicon Research’s long term earnings path depends on how one quiet pressure on its future pricing power actually plays out.

That pricing pressure question is exactly what the full narrative for Rubicon Research unpacks, surfacing where expansion plans could accelerate earnings power and where margins might quietly stall.

NSEI:RUBICON Revenue & Expenses Breakdown as at Nov 2026
NSEI:RUBICON Revenue & Expenses Breakdown as at Nov 2026

Tonbo Imaging India (NSEI:TONBO)

Tonbo Imaging India builds electro optical and infrared vision systems for defense and security forces, directly tied to fast growing demand for advanced sensing gear. The business generates about ₹3.3b from vision technology based products and solutions and carries a market value of roughly ₹74.7b.

Tonbo Imaging India taps the screener theme through its defense grade EO/IR and AI vision hardware, with earnings forecast to grow faster than the broader market while the stock trades on a rich P/S multiple that assumes strong execution. Interest is well earned, although future returns hinge on how one pressure on profitability resolves.

That profitability hinge is exactly what the 1 key reward and 3 important warning signs (2 are major!) unpacks so you can see where Tonbo Imaging India’s execution risk might be masking its real upside potential.

NSEI:TONBO P/S Ratio as at Nov 2026
NSEI:TONBO P/S Ratio as at Nov 2026

Bajel Projects (NSEI:BAJEL)

Bajel Projects is a pure play on India’s power build out, delivering EPC work on extra high voltage transmission and distribution lines. This business fits squarely with the fast growth grid expansion theme. It earns about ₹27.5b from power transmission and distribution and carries a roughly ₹18.6b market value.

Earnings grew 71% over the past year and analysts expect Bajel Projects’ profit to compound about 57.7% annually, fed by large EPC contracts for 765 kV and 400 kV lines and substations. The catch is what happens to those very slim 0.8% margins if one unseen pressure on future pricing and funding costs shifts.

If that funding squeeze is what you are worried about, go straight to the Bajel Projects financial health report to see how Bajel Projects’ balance sheet could absorb a margin shock.

NSEI:BAJEL Revenue & Expenses Breakdown as at Nov 2026
NSEI:BAJEL Revenue & Expenses Breakdown as at Nov 2026

Seeking Fresh Alternatives Before They Fly

Fresh breakouts rarely stay quiet for long. Momentum builds, prices move, and the best entry points can be gone before many investors arrive. Scan curated ideas now and consider acting early.